3,831 Shares in CME Group Inc. $CME Acquired by Fortis Capital Advisors LLC

Fortis Capital Advisors LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,831 shares of the financial services provider’s stock, valued at approximately $1,016,000.

A number of other large investors have also added to or reduced their stakes in the stock. Great Lakes Advisors LLC boosted its holdings in shares of CME Group by 2.3% in the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after purchasing an additional 37 shares in the last quarter. SeaCrest Wealth Management LLC boosted its holdings in shares of CME Group by 3.0% in the 1st quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider’s stock valued at $366,000 after purchasing an additional 40 shares in the last quarter. OneAscent Financial Services LLC boosted its holdings in shares of CME Group by 4.0% in the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock valued at $293,000 after purchasing an additional 43 shares in the last quarter. Ballentine Partners LLC boosted its holdings in shares of CME Group by 0.8% in the 1st quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider’s stock valued at $1,546,000 after purchasing an additional 45 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC boosted its holdings in shares of CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider’s stock valued at $356,000 after purchasing an additional 47 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of a number of research analyst reports. Barclays set a $298.00 target price on CME Group and gave the company an “equal weight” rating in a report on Thursday, July 24th. Citigroup raised their target price on CME Group from $265.00 to $275.00 and gave the company a “neutral” rating in a report on Thursday, July 3rd. Piper Sandler raised their target price on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Finally, Erste Group Bank cut CME Group from a “strong-buy” rating to a “hold” rating in a research note on Saturday, May 24th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $260.60.

CME Group Stock Down 0.4%

Shares of CME opened at $261.53 on Wednesday. CME Group Inc. has a 52 week low of $212.38 and a 52 week high of $290.79. The stock has a market capitalization of $94.25 billion, a price-to-earnings ratio of 25.32, a PEG ratio of 4.75 and a beta of 0.43. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a fifty day moving average of $274.42 and a 200-day moving average of $270.18.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $2.56 EPS. As a group, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard bought 256 shares of the stock in a transaction that occurred on Wednesday, June 25th. The stock was acquired at an average cost of $270.53 per share, with a total value of $69,255.68. Following the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.